News from alexza pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 14, 2014, 09:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Pharmaceuticals Provides an Update on the Five Post-EMA Approval Studies for ADASUVE®

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on its European Medicines Agency (EMA) post-approval studies for...

Aug 08, 2014, 09:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Pharmaceuticals Announces the Launch of ADASUVE® (inhalation powder, loxapine) in Guatemala

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that ADASUVE® inhalation powder, pre-dispensed (loxapine) is now available in...

Aug 07, 2014, 16:05 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Reports 2014 Second Quarter Financial Results

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter ended June 30, 2014.  The net loss for the...

Jul 31, 2014, 16:15 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Provides Pipeline Update

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on its pipeline and new product development efforts. In the second...

Jul 29, 2014, 16:15 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it is participating in two healthcare conferences during the third quarter,...

Jul 17, 2014, 16:15 ET

Alexza to Report 2014 Second Quarter Financial Results on Thursday, August 7, 2014

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal quarter ended June 30, 2014 on Thursday, August 7, 2014,...

Jun 30, 2014, 16:15 ET

Alexza Announces the Promotion of Edwin S. Kamemoto, Ph.D. to Senior Vice President, Regulatory Affairs

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced the promotion of Edwin S. Kamemoto, Ph.D., to the newly created position of Senior Vice...

May 05, 2014, 16:05 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Reports 2014 First Quarter Financial Results

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter ended March 31, 2014.  The net loss for the first...

Apr 30, 2014, 16:05 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Pharmaceuticals Announces the Launch of ADASUVE® (inhalation powder, loxapine) in the Nordic Countries

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that ADASUVE® inhalation powder, pre-dispensed (loxapine) is now available in...

Apr 17, 2014, 09:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Winston R. Brown, Jr. Joins Alexza Pharmaceuticals as Vice President, Quality

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that Winston R. Brown, Jr. has joined the Company as Vice President,...

Apr 16, 2014, 16:30 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza to Report 2014 First Quarter Financial Results on Monday, May 5, 2014

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal quarter ended March 31, 2014 on Monday, May 5, 2014, following the...

Mar 19, 2014, 09:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Pharmaceuticals Announces Private Placement of $45 Million of Non-Recourse Notes

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) (Alexza) announced today that it has closed a private placement to institutional investors of $45.0...

Mar 13, 2014, 09:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Pharmaceuticals and Ferrer Announce the Launch of ADASUVE® (inhalation powder, loxapine) in Romania

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Ferrer today announced that ADASUVE® inhalation powder, pre-dispensed (loxapine) is now...

Mar 06, 2014, 16:05 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Reports Fourth Quarter and Year End 2013 Financial Results

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter and year ended December 31, 2013.  The net...

Mar 03, 2014, 08:07 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Announces the U.S. Commercial Launch of ADASUVE® by Teva Pharmaceuticals

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced the U.S. commercial launch of ADASUVE® (loxapine) inhalation powder 10mg by its...

Feb 25, 2014, 09:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Robert A. Lippe Joins Alexza Pharmaceuticals as Executive Vice President, Operations and Chief Operations Officer

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that Robert A. Lippe has joined the Company as Executive Vice President, Operations...

Feb 20, 2014, 17:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Pharmaceuticals' Corporate Presentation to be Webcast from Two Upcoming March Investor Conferences

Alexza Pharmaceuticals' Corporate Presentation to be Webcast from Two Upcoming March Investor Conferences /* Style Definitions...

Feb 13, 2014, 09:00 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza to Report 2013 Year-End Financial Results on Thursday, March 6, 2014

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal year ended December 31, 2013 on Thursday, March 6, 2014, following...

Jan 21, 2014, 09:05 ET
Alexza Pharmaceuticals.  (PRNewsFoto/Alexza Pharmaceuticals, Inc.)

Alexza Pharmaceuticals Announces Ferrer's Launch of ADASUVE® (Staccato® Loxapine) in Spain Triggering a $1 Million Milestone Payment

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that ADASUVE® inhalation powder, pre-dispensed (Staccato® loxapine) is...

Nov 21, 2013, 16:15 ET

Alexza Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference

 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the Company will participate in the 25th Annual Piper Jaffray Healthcare...